Register for free to listen to this article
Listen with Speechify
0:00
1:00
PISCATAWAY, N.J.—GenScript has signed a biology researchcollaboration with Roche Research & Development Center (RRDC) to provideassay development services for potential drug targets in line with Roche's drugdevelopment portfolio.
 
Recognizing the distinct advantages that CRO providersoffer, many pharmaceutical companies have adapted an outsourcing strategy toincrease productivity and offset costs.
 
 
GenScript is a contract research organization (CRO) focusedin biological research and drug discovery services. Its service portfolioincludes bio-reagent services, assay development & screening, lead optimizationand antibody drug development.
 
"After the success of medicinal chemistry outsourcing, biologyCRO is becoming a new trend in drug discovery. We expect a fruitfulcollaboration with GenScript in assay development," notes Dr. Li Chen, chiefscientific officer of RRDC in China.
 
Dr. Frank Zhang, CEO of GenScript, points out that being thefirst drug discovery based R&D center established in China by a leadingmultinational pharmaceutical company, RRDC is taking the lead again inexpanding into discovery biology arena.

"We appreciate the confidence that RRDC has shown in GenScript,and believe that the collaboration will mutually benefit us," he adds.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue